Surveillance in inflammatory bowel disease. Chromoendoscopy and digital mucosal enhancement

Gastrointestinal Endoscopy Clinics of North America

Volumn 23, Issue 3, 2013, Pages 679-694

  Naymagon, Steven ^a   Marion, James F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autofluorescence imaging; Chromoendoscopy; Colitis; Colonoscopy; Dysplasia; Inflammatory bowel disease; Narrow band imaging

Indexed keywords

METHYLENE BLUE;

AUTOFLUORESCENCE IMAGING; CANCER MORTALITY; CANCER RISK; CHROMOENDOSCOPY; CLINICAL PRACTICE; COLONOSCOPY; CONFOCAL LASER MICROSCOPY; CROHN DISEASE; DISEASE SURVEILLANCE; DNA DAMAGE; FALSE POSITIVE RESULT; GASTROINTESTINAL DYSPLASIA; HUMAN; INTESTINE BIOPSY; META ANALYSIS (TOPIC); MORBIDITY; MULTICENTER STUDY (TOPIC); NARROW BAND IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; WHITE LIGHT ENDOSCOPY;

ADENOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORING AGENTS; HUMANS; INDIGO CARMINE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; METHYLENE BLUE; MICROSCOPY, CONFOCAL; NARROW BAND IMAGING; OPTICAL IMAGING;

EID: 84878640590     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2013.03.008     Document Type: Review

References (45)

1. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361(21):2066-2078.
2. Loftus E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006, 35(3):517-531.
3. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48(4):526-535.
4. Canavan C., Abrams K.R., Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006, 23(8):1097-1104.
5. Ullman T.A., Itzkowitz S.H. Intestinal inflammation and cancer. Gastroenterology 2011, 140(6):1807-1816.
6. Karlén P., Kornfeld D., Broström O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42(5):711-714.
7. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101(10):1671-1675.
8. Rubin C.E., Haggitt R.C., Burmer G.C., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103(5):1611-1620.
9. Rodriguez S.A., Collins J.M., Knigge K.L., et al. Surveillance and management of dysplasia in ulcerative colitis. Gastrointest Endosc 2007, 65(3):432-439.
10. van den Broek F.J., Stokkers P.C., Reitsma J.B., et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol 2011, [Epub ahead of print].
11. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60(3):334-339.
12. Jess T., Simonsen J., Jørgensen K.T., et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012, 143(2):375-381.
13. Rubin D.T., Rothe J.A., Hetzel J.T., et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?. Gastrointest Endosc 2007, 65(7):998-1004.
14. Kwon R.S., Adler D.G., Chand B., et al. High-resolution and high-magnification endoscopes. Gastrointest Endosc 2009, 69(3 Pt 1):399-407.
15. Buchner A.M., Shahid M.W., Heckman M.G., et al. High-definition colonoscopy detects colorectal polyps at a higher rate than standard white-light colonoscopy. Clin Gastroenterol Hepatol 2010, 8(4):364-370.
16. Subramanian V., Ramappa V., Telakis E., et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2012, 19(2):350-355.
17. Matsumoto T., Kudo T., Iida M. The significance of NBI observation for inflammatory bowel diseases. Comprehensive atlas of high resolution endoscopy and narrowband imaging 2008, 149-160. Blackwell Publishing, Oxford (United Kingdom). J. Cohen (Ed.).
18. Dekker E., van den Broek F.J., Reitsma J.B., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007, 39(3):216-221.
19. van den Broek F.J., Fockens P., van Eeden S., et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011, 43(2):108-115.
20. Ignjatovic A., East J.E., Subramanian V., et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012, 107(6):885-890.
21. Pellisé M., López-Cerón M., Rodríguez de Miguel C., et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011, 74(4):840-848.
22. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124(4):880-888.
23. Kiesslich R., Neurath M.F. Chromoendoscopy in inflammatory bowel disease. Gastroenterol Clin North Am 2012, 41(2):291-302.
24. Matsumoto T., Nakamura S., Jo Y., et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003, 98(8):1827-1833.
25. Kiesslich R., Goetz M., Lammersdorf K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007, 132(3):874-882.
26. Hurlstone D.P., Sanders D.S., Lobo A.J., et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005, 37(12):1186-1192.
27. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53(2):256-260.
28. Marion J.F., Waye J.D., Present D.H., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103(9):2342-2349.
29. Subramanian V., Mannath J., Ragunath K., et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33(3):304-312.
30. Davies J., Burke D., Olliver J.R., et al. Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy. Gut 2007, 56(1):155-156.
31. Hardie L.J., Olliver J.R., Wild C.P., et al. Chromoendoscopy with methylene blue and the risk of DNA damage. Gastroenterology 2004, 126(2):623. [author reply: 623-4].
32. Sauk J., Hoffman A., Anandasabapathy S., et al. High-definition and filter-aided colonoscopy. Gastroenterol Clin North Am 2010, 39(4):859-881.
33. Pohl J., Lotterer E., Balzer C., et al. Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial. Gut 2009, 58(1):73-78.
34. Aminalai A., Rösch T., Aschenbeck J., et al. Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroenterol 2010, 105(11):2383-2388.
35. Chung S.J., Kim D., Song J.H., et al. Efficacy of computed virtual chromoendoscopy on colorectal cancer screening: a prospective, randomized, back-to-back trial of Fuji Intelligent Color Enhancement versus conventional colonoscopy to compare adenoma miss rates. Gastrointest Endosc 2010, 72(1):136-142.
36. Hoffman A., Sar F., Goetz M., et al. High definition colonoscopy combined with i-Scan is superior in the detection of colorectal neoplasias compared with standard video colonoscopy: a prospective randomized controlled trial. Endoscopy 2010, 42(10):827-833.
37. Hoffman A., Kagel C., Goetz M., et al. Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy. Dig Liver Dis 2010, 42(1):45-50.
38. Goetz M. Colonoscopic surveillance in inflammatory bowel disease: state of the art reduction of biopsies. Dig Dis 2011, 29(Suppl 1):36-40.
39. Fusco V., Ebert B., Weber-Eibel J., et al. Cancer prevention in ulcerative colitis: long-term outcome following fluorescence-guided colonoscopy. Inflamm Bowel Dis 2012, 18(3):489-495.
40. Messmann H., Endlicher E., Freunek G., et al. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. Gut 2003, 52(7):1003-1007.
41. van den Broek F.J., Fockens P., van Eeden S., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 2008, 57(8):1083-1089.
42. Günther U., Kusch D., Heller F., et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis 2011, 26(5):667-672.
43. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105(3):501-523.
44. Farraye F.A., Odze R.D., Eaden J., et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138(2):746-774.
45. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59(5):666-689.